Allergan Sues Again To Block Generic Latisse
By Keith Goldberg · August 18, 2011, 7:03 PM EDT
Allergan Inc. filed a patent infringement suit against Hi-Tech Pharmacal Co. Inc. in North Carolina on Wednesday in its latest effort to block a generic version of the eyelash growth treatment...
To view the full article, register now.